Search

Your search keyword '"Flachskampf, Frank A."' showing total 18 results
Start Over Author "Flachskampf, Frank A." Topic cardiology
18 results on '"Flachskampf, Frank A."'

1. Three-dimensional transoesophageal echocardiography: how to use and when to use-a clinical consensus statement from the European Association of Cardiovascular Imaging of the European Society of Cardiology.

Author

Faletra FF, Agricola E, Flachskampf FA, Hahn R, Pepi M, Ajmone Marsan N, Wunderlich N, Elif Sade L, Donal E, Zamorano JL, Cosyns B, Vannan M, Edvardsen T, Berrebi A, Popescu BA, Lancellotti P, Lang R, Bäck M, Bertrand PB, Dweck M, Keenan N, and Stankovic I

Subjects
Humans, Echocardiography, Transesophageal methods, Heart, Echocardiography, Three-Dimensional methods, Cardiovascular System, Cardiology
Abstract

Three-dimensional transoesophageal echocardiography (3D TOE) has been rapidly developed in the last 15 years. Currently, 3D TOE is particularly useful as an additional imaging modality for the cardiac echocardiographers in the echo-lab, for cardiac interventionalists as a tool to guide complex catheter-based procedures cardiac, for surgeons to plan surgical strategies, and for cardiac anaesthesiologists and/or cardiologists, to assess intra-operative results. The authors of this document believe that acquiring 3D data set should become a 'standard part' of the TOE examination. This document provides (i) a basic understanding of the physic of 3D TOE technology which enables the echocardiographer to obtain new skills necessary to acquire, manipulate, and interpret 3D data sets, (ii) a description of valvular pathologies, and (iii) a description of non-valvular pathologies in which 3D TOE has shown to be a diagnostic tool particularly valuable. This document has a new format: instead of figures randomly positioned through the text, it has been organized in tables which include figures. We believe that this arrangement makes easier the lecture by clinical cardiologists and practising echocardiographers., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Published
2023
Full Text
View/download PDF

2. Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Author

Mancusi C, de Simone G, Brguljan Hitij J, Sudano I, Mahfoud F, Parati G, Kahan T, Barbato E, Pierard LA, Garbi M, Flachskampf FA, and Gerdts E

Subjects
Humans, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis surgery, Cardiology, Heart Valve Diseases complications, Hypertension complications, Hypertension diagnosis, Hypertension drug therapy
Abstract

Aortic valve stenosis (AS) is the third most common cardiovascular disease. The prevalence of both AS and arterial hypertension increases with age, and the conditions therefore often co-exist. Co-existence of AS and arterial hypertension is associated with higher global left ventricular (LV) pressure overload, more abnormal LV geometry and function, and more adverse cardiovascular outcome. Arterial hypertension may also influence grading of AS, leading to underestimation of the true AS severity. Current guidelines suggest re-assessing patients once arterial hypertension is controlled. Management of arterial hypertension in AS has historically been associated with prudence and concerns, mainly related to potential adverse consequences of drug-induced peripheral vasodilatation combined with reduced stroke volume due to the fixed LV outflow obstruction. Current evidence suggests that patients should be treated with antihypertensive drugs blocking the renin-angiotensin-aldosterone system, adding further drug classes when required, to achieve similar target blood pressure (BP) values as in hypertensive patients without AS. The introduction of transcatheter aortic valve implantation has revolutionized the management of patients with AS, but requires proper BP management during and following valve replacement. The purpose of this document is to review the recent evidence and provide practical expert advice on management of hypertension in patients with AS., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)

Published
2021
Full Text
View/download PDF

3. Development, validation, and implementation of biomarker testing in cardiovascular medicine state-of-the-art: proceedings of the European Society of Cardiology-Cardiovascular Round Table.

Author

Elliott P, Cowie MR, Franke J, Ziegler A, Antoniades C, Bax J, Bucciarelli-Ducci C, Flachskampf FA, Hamm C, Jensen MT, Katus H, Maisel A, McDonagh T, Mittmann C, Muntendam P, Nagel E, Rosano G, Twerenbold R, and Zannad F

Subjects
Biomarkers blood, Cardiovascular Diseases blood, Cardiovascular Diseases physiopathology, Cardiovascular Diseases therapy, Humans, Predictive Value of Tests, Prognosis, Reproducibility of Results, Biomedical Research, Cardiology, Cardiovascular Diseases diagnosis, Echocardiography, Magnetic Resonance Imaging, Troponin T blood, Ventricular Function, Left
Abstract

Many biomarkers that could be used to assess ejection fraction, heart failure, or myocardial infarction fail to translate into clinical practice because they lack essential performance characteristics or fail to meet regulatory standards for approval. Despite their potential, new technologies have added to the complexities of successful translation into clinical practice. Biomarker discovery and implementation require a standardized approach that includes: identification of a clinical need; identification of a valid surrogate biomarker; stepwise assay refinement, demonstration of superiority over current standard-of-care; development and understanding of a clinical pathway; and demonstration of real-world performance. Successful biomarkers should improve efficacy or safety of treatment, while being practical at a realistic cost. Everyone involved in cardiovascular healthcare, including researchers, clinicians, and industry partners, are important stakeholders in facilitating the development and implementation of biomarkers. This article provides suggestions for a development pathway for new biomarkers, discusses regulatory issues and challenges, and suggestions for accelerating the pathway to improve patient outcomes. Real-life examples of successful biomarkers-high-sensitivity cardiac troponin, T2* cardiovascular magnetic resonance imaging, and echocardiography-are used to illustrate the value of a standardized development pathway in the translation of concepts into routine clinical practice., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)

Published
2021
Full Text
View/download PDF

4. Training, competence, and quality improvement in echocardiography: the European Association of Cardiovascular Imaging Recommendations: update 2020.

Author

Popescu BA, Stefanidis A, Fox KF, Cosyns B, Delgado V, Di Salvo GD, Donal E, Flachskampf FA, Galderisi M, Lancellotti P, Muraru D, Sade LE, and Edvardsen T

Subjects
Echocardiography, Europe, Humans, Quality Improvement, Societies, Medical, Cardiology, Cardiovascular Diseases diagnostic imaging
Abstract

The primary mission of the European Association of Cardiovascular Imaging (EACVI) is 'to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging'. Echocardiography is a key component in the evaluation of patients with known or suspected cardiovascular disease and is essential for the high quality and effective practice of clinical cardiology. The EACVI aims to update the previously published recommendations for training, competence, and quality improvement in echocardiography since these activities are increasingly recognized by patients, physicians, and payers. The purpose of this document is to provide the general requirements for training and competence in echocardiography, to outline the principles of quality evaluation, and to recommend a set of measures for improvement, with the ultimate goal of raising the standards of echocardiographic practice. Moreover, the document aims to provide specific guidance for advanced echo techniques, which have dramatically evolved since the previous publication in 2009., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.)

Published
2020
Full Text
View/download PDF

5. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).

Author

Čelutkienė J, Pudil R, López-Fernández T, Grapsa J, Nihoyannopoulos P, Bergler-Klein J, Cohen-Solal A, Farmakis D, Tocchetti CG, von Haehling S, Barberis V, Flachskampf FA, Čeponienė I, Haegler-Laube E, Suter T, Lapinskas T, Prasad S, de Boer RA, Wechalekar K, Anker MS, Iakobishvili Z, Bucciarelli-Ducci C, Schulz-Menger J, Cosyns B, Gaemperli O, Belenkov Y, Hulot JS, Galderisi M, Lancellotti P, Bax J, Marwick TH, Chioncel O, Jaarsma T, Mullens W, Piepoli M, Thum T, Heymans S, Mueller C, Moura B, Ruschitzka F, Zamorano JL, Rosano G, Coats AJS, Asteggiano R, Seferovic P, Edvardsen T, and Lyon AR

Subjects
Antineoplastic Agents adverse effects, Female, Humans, Vascular Endothelial Growth Factor A, Cardiology, Heart Failure, Neoplasms drug therapy
Abstract

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed., (© 2020 European Society of Cardiology.)

Published
2020
Full Text
View/download PDF

6. Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

Author

Čelutkienė J, Plymen CM, Flachskampf FA, de Boer RA, Grapsa J, Manka R, Anderson L, Garbi M, Barberis V, Filardi PP, Gargiulo P, Zamorano JL, Lainscak M, Seferovic P, Ruschitzka F, Rosano GMC, and Nihoyannopoulos P

Subjects
Europe, Exercise Test, Humans, Cardiac Imaging Techniques methods, Cardiology, Consensus, Heart Failure diagnosis, Societies, Medical
Abstract

Myriad advances in all fields of cardiac imaging have stimulated and reflected new understanding of cardiac performance, myocardial damage and the mechanisms of heart failure. In this paper, the Heart Failure Association assesses the potential usefulness of innovative imaging modalities in enabling more precise diagnostic and prognostic evaluation, as well as in guiding treatment strategies. Many new methods have gradually penetrated clinical practice and are on their way to becoming a part of routine evaluation. This paper focuses on myocardial deformation and three-dimensional ultrasound imaging; stress tests for the evaluation of contractile and filling function; the progress of magnetic resonance techniques; molecular imaging and other sound innovations. The Heart Failure Association aims to highlight the ways in which paradigms have shifted in several areas of cardiac assessment. These include reassessing of the simplified concept of ejection fraction and implementation of the new parameters of cardiac performance applicable to all heart failure phenotypes; switching from two-dimensional to more accurate and reproducible three-dimensional ultrasound volumetric evaluation; greater tissue characterization via recently developed magnetic resonance modalities; moving from assessing cardiac function and congestion at rest to assessing it during stress; from invasive to novel non-invasive hybrid techniques depicting coronary anatomy and myocardial perfusion; as well as from morphometry to the imaging of pathophysiologic processes such as inflammation and apoptosis. This position paper examines the specific benefits of imaging innovations for practitioners dealing with heart failure aetiology, risk stratification and monitoring, and, in addition, for scientists involved in the development of future research., (© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.)

Published
2018
Full Text
View/download PDF

7. Recommendations for transoesophageal echocardiography: EACVI update 2014.

Author

Flachskampf FA, Wouters PF, Edvardsen T, Evangelista A, Habib G, Hoffman P, Hoffmann R, Lancellotti P, and Pepi M

Subjects
Aortic Diseases diagnostic imaging, Atrial Appendage diagnostic imaging, Endocarditis, Bacterial diagnostic imaging, Europe, Guidelines as Topic, Heart Defects, Congenital diagnostic imaging, Heart Valve Diseases diagnostic imaging, Humans, Societies, Medical, Ultrasonography, Interventional methods, Cardiology, Echocardiography, Three-Dimensional methods, Echocardiography, Transesophageal methods, Heart Diseases diagnostic imaging
Abstract

With this document, we update the recommendations for transoesophageal echocardiography (TOE) of the European Association of Cardiovascular Imaging. The document focusses on the areas of interventional TOE, in particular transcatheter aortic, mitral, and left atrial appendage interventions, as well as on the role of TOE in infective endocarditis, adult congenital heart disease, and aortic disease.

Published
2014
Full Text
View/download PDF

8. Reimbursement and the practice of cardiology.

Author

Flachskampf FA, von Erffa J, and Seligmann C

Subjects
Cardiology trends, Female, Forecasting, Germany, Health Care Costs, Health Care Reform, Health Care Surveys, Humans, Insurance, Health, Reimbursement economics, Insurance, Health, Reimbursement trends, Male, Practice Patterns, Physicians' economics, Practice Patterns, Physicians' trends, Cardiology economics, Quality of Health Care, Reimbursement Mechanisms economics, Reimbursement Mechanisms trends
Published
2012
Full Text
View/download PDF

9. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging

Author

Smiseth, Otto A, Morris, Daniel A, Cardim, Nuno, Cikes, Maja, Delgado, Victoria, Donal, Erwan, Flachskampf, Frank A, Galderisi, Maurizio, Gerber, Bernhard, Gimelli, Alessia, Klein, Allan L, Knuuti, Juhani, Lancellotti, Patrizio, Mascherbauer, Julia, Milicic, Davor, Seferovic, Petar, Solomon, Scott, Edvardsen, Thor, Popescu, Bogdan A, Reviewers: This document was reviewed by members of the 2018–2020 EACVI Scientific Documents Committee, UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire, UCL - (SLuc) Service de pathologie cardiovasculaire, Oslo University Hospital [Oslo], Charité Campus Virchow-Klinikum (CVK), University of Zagreb, Leiden University Medical Center (LUMC), Universiteit Leiden, Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Uppsala University Hospital, 'Federico II' University of Naples Medical School, Cliniques universitaires St Luc [Bruxelles], Université Catholique de Louvain = Catholic University of Louvain (UCL), Fondazione Toscana Gabriele Monasterio, Cleveland Clinic, University of Turku, Université de Liège, Clinical Center of Serbia (KCS), Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Clinical sciences, Cardio-vascular diseases, and Cardiology

Subjects
medicine.medical_specialty, Consensus, Diastole, heart failure, echocardiography, diastole, filling pressure, multimodality imaging, 030204 cardiovascular system & hematology, Ventricular Function, Left, MECHANISMS, Ventricular Dysfunction, Left, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, diabetic cardiomyopathy, medicine, Humans, Radiology, Nuclear Medicine and imaging, In patient, 030212 general & internal medicine, Heart Failure, Ejection fraction, diabetes, business.industry, Expert consensus, Stroke Volume, General Medicine, Prognosis, medicine.disease, 3. Good health, Heart failure, Screening, Cardiology, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, business, Heart failure with preserved ejection fraction
Abstract

Nearly half of all patients with heart failure (HF) have a normal left ventricular (LV) ejection fraction (EF) and the condition is termed heart failure with preserved ejection fraction (HFpEF). It is assumed that in these patients HF is due primarily to LV diastolic dysfunction. The prognosis in HFpEF is almost as severe as in HF with reduced EF (HFrEF). In contrast to HFrEF where drugs and devices are proven to reduce mortality, in HFpEF there has been limited therapy available with documented effects on prognosis. This may reflect that HFpEF encompasses a wide range of different pathological processes, which multimodality imaging is well placed to differentiate. Progress in developing therapies for HFpEF has been hampered by a lack of uniform diagnostic criteria. The present expert consensus document from the European Association of Cardiovascular Imaging (EACVI) provides recommendations regarding how to determine elevated LV filling pressure in the setting of suspected HFpEF and how to use multimodality imaging to determine specific aetiologies in patients with HFpEF.

Published
2021

10. Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging

Author

Galderisi, Maurizio, Cosyns, Bernard, Edvardsen, Thor, Cardim, Nuno, Delgado, Victoria, Di Salvo, Giovanni, Donal, Erwan, Sade, Leyla Elif, Ernande, Laura, Garbi, Madalina, Grapsa, Julia, Hagendorff, Andreas, Kamp, Otto, Magne, Julien, Santoro, Ciro, Stefanidis, Alexandros, Lancellotti, Patrizio, Popescu, Bogdan, Habib, Gilbert, Flachskampf, Frank A., Gerber, Bernhard, Gimelli, Alessia, Haugaa, Kristina, Università degli studi di Napoli Federico II, Academisch Ziekenhuis Vrije Universiteit Brussel, Oslo University Hospital [Oslo], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10, Imperial College London, Universität Leipzig [Leipzig], Service de cardiologie [CHU Limoges], CHU Limoges, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA-Research), Université de Liège, Unité de Recherche sur les Maladies Infectieuses Tropicales Emergentes (URMITE), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), University of Naples Federico II = Università degli studi di Napoli Federico II, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Universität Leipzig, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Galderisi, Maurizio, Cosyns, Bernard, Edvardsen, Thor, Cardim, Nuno, Delgado, Victoria, Di Salvo, Giovanni, Donal, Erwan, Sade, Leyla Elif, Ernande, Laura, Garbi, Madalina, Grapsa, Julia, Hagendorff, Andrea, Kamp, Otto, Magne, Julien, Santoro, Ciro, Stefanidis, Alexandro, Lancellotti, Patrizio, Popescu, Bogdan, Habib, Gilbert, Flachskampf, Frank A., Gerber, Bernhard, Gimelli, Alessia, Haugaa, Kristina, Cardio-vascular diseases, Clinical sciences, Cardiology, ACS - Heart failure & arrhythmias, and DI SALVO, Giovanni

Subjects
Male, Radiology, Nuclear Medicine and Imaging, heart valve disease, Heart Valve Diseases, 030204 cardiovascular system & hematology, 0302 clinical medicine, Diastole, 030212 general & internal medicine, Societies, Medical, Body surface area, Ejection fraction, valvular heart disease, diastolic function, General Medicine, Reference Standards, 3. Good health, Europe, medicine.anatomical_structure, Echocardiography, Radiology Nuclear Medicine and imaging, echocardiographic report, Practice Guidelines as Topic, Cardiology, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, global longitudinal strain, Artery, Adult, medicine.medical_specialty, Consensus, Heart Ventricles, 03 medical and health sciences, Internal medicine, Medical, medicine, Humans, Heart valve, Heart Atria, chamber quantification, 3D echocardiography, business.industry, medicine.disease, Pulmonary hypertension, Cardiac Imaging Techniques, Blood pressure, Heart failure, business, Societies
Abstract

This European Association Cardiovascular Imaging (EACVI) Expert Consensus document aims at defining the main quantitative information on cardiac structure and function that needs to be included in standard echocardiographic report following recent ASE/EACVI chamber quantification, diastolic function, and heart valve disease recommendations. The document focuses on general reporting and specific pathological conditions such as heart failure, coronary artery and valvular heart disease, cardiomyopathies, and systemic diseases. Aims This European Association Cardiovascular Imaging (EACVI) Expert Consensus document aims at defining the main quantitative information on cardiac structure and function that needs to be included in standard echocardiographic report following recent ASE/EACVI chamber quantification, diastolic function, and heart valve disease recommendations. The document focuses on general reporting and specific pathological conditions such as heart failure, coronary artery and valvular heart disease, cardiomyopathies, and systemic diseases.Methods and results Demographic data (age, body surface area, blood pressure, and heart rhythm and rate), type (vendor and model) of ultrasound system used and image quality need to be reported. In addition, measurements should be normalized for body size. Reference normal values, derived by ASE/EACVI recommendations, shall always be reported to differentiate normal from pathological conditions. This Expert Consensus document suggests avoiding the surveillance of specific variable using different ultrasound techniques (e.g. in echo labs with high expertise in left ventricular ejection fraction by 3D and not by 2D echocardiography). The report should be also tailored in relation with different cardiac pathologies, quality of images, and needs of the caregivers.Conclusion The conclusion should be concise reflecting the status of left ventricular structure and function, the presence of left atrial and/or aortic dilation, right ventricular dysfunction, and pulmonary hypertension, leading to an objective communication with the patient health caregiver. Variation over time should be considered carefully, taking always into account the consistency of the parameters used for comparison.

Published
2017

11. Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging.

Author

Fox, Kevin, Achenbach, Stephan, Bax, Jeroen, Cosyns, Bernard, Delgado, Victoria, Dweck, Marc R, Edvardsen, Thor, Flachskampf, Frank, Habib, Gilbert, Lancellotti, Patrizio, Muraru, Denisa, Neglia, Danilo, Pontone, Gianluca, Schwammenthal, Ehud, Sechtem, Udo, Westwood, Mark, and Popescu, Bogdan A

Abstract

View large Download slide View large Download slide [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

12. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases

Author

Adler, Yehuda, Charron, Philippe, Imazio, Massimo, Badano, Luigi, Barón Esquivias, Gonzalo, Bogaert, Jan, Brucato, Antonio, Gueret, Pascal, Klingel, Karin, Lionis, Christos, Maisch, Bernhard, Mayosi, Bongani, Pavie, Alain, Ristić, Arsen D., Tenas, Manel Sabaté, Seferovic, Petar, Swedberg, Karl, Tomkowski, Witold, Achenbach, Stephan, Agewall, Stefan, Al Attar, Nawwar, Ferrer, Juan Angel, Arad, Michael, Asteggiano, Riccardo, Bueno, Héctor, Caforio, Alida L. P., Carerj, Scipione, Ceconi, Claudio, Evangelista, Arturo, Flachskampf, Frank, Giannakoulas, George, Gielen, Stephan, Habib, Gilbert, Kolh, Philippe, Lambrinou, Ekaterini, Lancellotti, Patrizio, Lazaros, George, Linhart, Ales, Meurin, Philippe, Nieman, Koen, Piepoli, Massimo F., Price, Susanna, Roos Hesselink, Jolien, Zamorano, Jose Luis, Aboyans, Victor, Badimon, Lina, Baumgartner, Helmut, Bax, Jeroen J., Dean, Veronica, Erol, Cetin, Fitzimons, Donna, Gaemperli, Oliver, Kirchhof, Paulus, Lip, Gregory Y. H., Nihoyannopoulos, Petros, Ponikowski, Piotr, Roffi, Marco, Torbicki, Adam, Carneiro, Antonio Vaz, Windecker, Stephan, Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, and Windecker, S

Subjects
Male, Cardiac Catheterization, Pathology, Multimodal Imaging, Heart Neoplasms, Kidney Failure, Pericarditis, Myocardial infarction, Aetiology, Chronic, Tomography, Societies, Medical, Pericardiocentesis, General Medicine, Constrictive pericarditis, Diagnosis, Guidelines, Myopericarditis, Pericardial effusion, Pericardium, Prognosis, Tamponade, Therapy, Cardiothoracic surgery, Echocardiography, Acute Disease, Pericardial diseases, cardiovascular system, Drainage, Antibody, Cardiology and Cardiovascular Medicine, medicine.medical_specialty, Congenital cytomegalovirus infection, Guidelines, Aetiology, Constrictive pericarditis, Diagnosis, Myopericarditis, Pericardial effusion, Pericardiocentesis, Pericarditis, Pericardium, Prognosis, Tamponade, Therapy, Text mining, Humans, Radiation Injuries, Physical Examination, medicine.disease, Cardiac Tamponade, Heart Injuries, chemistry, Positron-Emission Tomography, Kidney Failure, Chronic, Creatine kinase, Triage, Biomarkers, Magnetic Resonance Angiography, Biopsy, Basic fibroblast growth factor, Anti-Inflammatory Agents, Medical and Health Sciences, chemistry.chemical_compound, Postoperative Complications, Adenosine deaminase, Recurrence, reproductive and urinary physiology, Age Factors, Autoimmune Diseases, Bacterial Infections, Chronic Disease, Endoscopy, Hospitalization, Sex Factors, Syndrome, Tomography, X-Ray Computed, Treatment Outcome, Virus Diseases, Pericardial Effusion, biology, Medicine (all), Thoracic Surgery, X-Ray Computed, Europe, medicine.anatomical_structure, Infective endocarditis, embryonic structures, Cardiology, Female, biological phenomena, cell phenomena, and immunity, Esc Guidelines, Heart Diseases, Acute pericarditis, Internal medicine, medicine, Diseases of the circulatory (Cardiovascular) system, cardiovascular diseases, urogenital system, Task force, business.industry, RC666-701, biology.protein, business
Abstract

ADA : adenosine deaminase AMI : acute myocardial infarction ANA : anti-nuclear antibody bFGF : basic fibroblast growth factor CK : creatine kinase CMR : cardiac magnetic resonance CMV : cytomegalovirus CP : Child–Pugh CRP : C-reactive protein CT : computed tomography EBV

Published
2015

13. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Author

Lang, Roberto M., Badano, Luigi P., Mor-Avi, Victor, Afilalo, Jonathan, Armstrong, Anderson, Ernande, Laura, Flachskampf, Frank A., Foster, Elyse, Goldstein, Steven A., Kuznetsova, Tatiana, Lancellotti, Patrizio, Muraru, Denisa, Picard, Michael H., Rietzschel, Ernst R., Rudski, Lawrence, Spencer, Kirk T., Tsang, Wendy, and Voigt, Jens-Uwe

Subjects
LEFT heart ventricle, HEART physiology, AORTA, HEART beat, LEFT heart atrium, RIGHT heart atrium, BIOPHYSICS, BLOOD pressure, CARDIAC output, CARDIOLOGY, CONFIDENCE intervals, DIAGNOSTIC imaging, ECHOCARDIOGRAPHY, MEDICAL societies, SCIENTIFIC method, ULTRASONIC imaging, VENA cava inferior, DATA analysis, PHYSIOLOGY, ANATOMY
Published
2015
Full Text
View/download PDF

14. Recommendations for transoesophageal echocardiography: EACVI update 2014.

Author

Flachskampf, Frank A., Wouters, Patrick F., Edvardsen, Thor, Evangelista, Artur, Habib, Gilbert, Hoffman, Piotr, Hoffmann, Rainer, Lancellotti, Patrizio, and Pepi, Mauro

Subjects
TRANSESOPHAGEAL echocardiography, CONGENITAL heart disease diagnosis, HEART anatomy, LEFT heart atrium, ANGIOPLASTY, AORTIC aneurysms, AORTIC valve diseases, CARDIOLOGY, DIAGNOSTIC imaging, AORTIC dissection, MEDICAL protocols, MEDICAL societies, OPERATIVE surgery, ANATOMY
Abstract

With this document, we update the recommendations for transoesophageal echocardiography (TOE) of the European Association of Cardiovascular Imaging. The document focusses on the areas of interventional TOE, in particular transcatheter aortic, mitral, and left atrial appendage interventions, as well as on the role of TOE in infective endocarditis, adult congenital heart disease, and aortic disease. [ABSTRACT FROM PUBLISHER]

Published
2014

15. How should tissue Doppler tracings be measured?

Author

Flachskampf, Frank A. and Mårtensson, Mattias

Subjects
HEART physiology, ULTRASONIC imaging, CARDIOLOGY, ECHOCARDIOGRAPHY, MEDICAL practice, MYOCARDIUM, SERIAL publications
Abstract

The author discusses ways tissue Doppler tracings should be measured. He says that additional research is needed into modal velocity measurements' reproducibility. He also discusses the technical differences between tissue Doppler and standard pulsed-wave Doppler and the efforts needed to determine and fix machine-related biases in such measurements.

Published
2014
Full Text
View/download PDF

16. Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Author

Felix Mahfoud, Emanuele Barbato, Jana Brguljan Hitij, Giovanni de Simone, Eva Gerdts, Gianfranco Parati, Madalina Garbi, Frank A. Flachskampf, Thomas Kahan, Luc Pierard, Costantino Mancusi, Isabella Sudano, University of Zurich, Mancusi, Costantino, de Simone, Giovanni, Hitij, Jana Brguljan, Sudano, Isabella, Mahfoud, Felix, Parati, Gianfranco, Kahan, Thoma, Barbato, Emanuele, Pierard, Luc A, Garbi, Madalina, Flachskampf, Frank A, and Gerdts, Eva

Subjects
cardiovascular risk, arterial hypertension, medicine.medical_specialty, Aortic valve stenosi, medicine.medical_treatment, Cardiology, Heart Valve Diseases, aortic valve calcification, 610 Medicine & health, 030204 cardiovascular system & hematology, Left ventricular hypertrophy, 03 medical and health sciences, 0302 clinical medicine, Valve replacement, Aortic valve replacement, Internal medicine, medicine, Humans, aortic valve replacement, Pharmacology (medical), 030212 general & internal medicine, Pressure overload, business.industry, valvular heart disease, Aortic Valve Stenosis, Stroke volume, medicine.disease, drug therapy, left ventricular hypertrophy, Blood pressure, Aortic valve stenosis, Hypertension, 10209 Clinic for Cardiology, prognosis, Cardiology and Cardiovascular Medicine, business
Abstract

Aortic valve stenosis (AS) is the third most common cardiovascular disease. The prevalence of both AS and arterial hypertension increases with age, and the conditions therefore often co-exist. Co-existence of AS and arterial hypertension is associated with higher global left ventricular (LV) pressure overload, more abnormal LV geometry and function, and more adverse cardiovascular outcome. Arterial hypertension may also influence grading of AS, leading to underestimation of the true AS severity. Current guidelines suggest re-assessing patients once arterial hypertension is controlled. Management of arterial hypertension in AS has historically been associated with prudence and concerns, mainly related to potential adverse consequences of drug-induced peripheral vasodilatation combined with reduced stroke volume due to the fixed LV outflow obstruction. Current evidence suggests that patients should be treated with antihypertensive drugs blocking the renin–angiotensin–aldosterone system, adding further drug classes when required, to achieve similar target blood pressure (BP) values as in hypertensive patients without AS. The introduction of transcatheter aortic valve implantation has revolutionized the management of patients with AS, but requires proper BP management during and following valve replacement. The purpose of this document is to review the recent evidence and provide practical expert advice on management of hypertension in patients with AS.

Published
2020

17. Interobserver Variability in Applying American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 Guidelines for Estimation of Left Ventricular Filling Pressure

Author

Jeroen J. Bax, Serge C. Harb, Kinan Carlos El Tallawi, Mohammed A. Chamsi-Pasha, Carmen C. Beladan, Saket Sanghai, Sherif F. Nagueh, Roberta Esposito, Steven A. Goldstein, Erwan Donal, Victoria Delgado, Giulia Dolci, Theodore P. Abraham, Frank A. Flachskampf, Patrizio Lancellotti, Arnaud Hubert, Allan L. Klein, Geneviève Derumeaux, Paolo Marino, Otto A. Smiseth, Gerard P. Aurigemma, Laura Ernande, Judy Hung, Thor Edvardsen, Redah Z. Mahmood, James L. Gentry, Alyssa Browning, Maurizio Galderisi, Jiaqiong Xu, Martina Previato, Bogdan A. Popescu, Nagueh, Sherif F., Abraham, Theodore P., Aurigemma, Gerard P., Bax, Jeroen J., Beladan, Carmen, Browning, Alyssa, Chamsi-Pasha, Mohammed A., Delgado, Victoria, Derumeaux, Genevieve, Dolci, Giulia, Donal, Erwan, Edvardsen, Thor, El Tallawi, Kinan Carlo, Ernande, Laura, Esposito, Roberta, Flachskampf, Frank A., Galderisi, Maurizio, Gentry, Jame, Goldstein, Steven A., Harb, Serge C., Hubert, Arnaud, Hung, Judy, Klein, Allan L., Lancellotti, Patrizio, Mahmood, Redah Z., Marino, Paolo, Popescu, Bogdan A., Previato, Martina, Sanghai, Saket R., Smiseth, Otto A., Xu, Jiaqiong, University of Massachusetts Medical School [Worcester] (UMASS), University of Massachusetts System (UMASS), Leiden University Medical Center (LUMC), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], University of Oslo (UiO), Uppsala University, Cleveland Clinic, Università degli Studi del Piemonte Orientale - Amedeo Avogadro (UPO), Universiteit Leiden, and Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
Male, medicine.medical_specialty, Radiology, Nuclear Medicine and Imaging, Heart Diseases, Heart Ventricles, echocardiography, Doppler, Diastole, 030204 cardiovascular system & hematology, Doppler echocardiography, Ventricular Function, Left, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, 0302 clinical medicine, diastole, Predictive Value of Tests, Internal medicine, medicine, Ventricular Pressure, echocardiography, human, humans, ComputingMilieux_MISCELLANEOUS, Aged, Estimation, Observer Variation, medicine.diagnostic_test, business.industry, Limits of agreement, Doppler, Reproducibility of Results, Guideline, Middle Aged, Practice Guidelines as Topic, Cardiology, Female, [SDV.IB]Life Sciences [q-bio]/Bioengineering, business, Ventricular filling, Cardiology and Cardiovascular Medicine, [SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing, guideline
Abstract

Background: Assessment of left ventricular (LV) filling pressure is among the important components of a comprehensive echocardiographic report. Previous studies noted wide limits of agreement using 2009 American Society of Echocardiography/European Association of Echocardiography guidelines, but reproducibility of 2016 guidelines update in estimating LV filling pressure is unknown. Methods: Echocardiographic and hemodynamic data were obtained from 50 patients undergoing cardiac catheterization for clinical indications. Clinical and echocardiographic findings but not invasive hemodynamics were provided to 4 groups of observers, including experienced echocardiographers and cardiology fellows. Invasively acquired LV filling pressure was the gold standard. Results: In group I of 8 experienced echocardiographers from the guidelines writing committee, sensitivity for elevated LV filling pressure was 92% for all observers, and specificity was 93±6%. Fleiss κ-value for the agreement in group I was 0.80. In group II of 4 fellows in training, sensitivity was 91±2%, and specificity was 95±2%. Fleiss κ-value for the agreement in group II was 0.94. In group III of 9 experienced echocardiographers who had not participated in drafting the guidelines, sensitivity was 88±5%, and specificity was 91±7%. Fleiss κ-value for the agreement in group III was 0.76. In group IV of 7 other fellows, sensitivity was 91±3%, and specificity was 92±5%. Fleiss κ-value for the agreement in group IV was 0.89. Conclusions: There is a good level of agreement and accuracy in the estimation of LV filling pressure using the American Society of Echocardiography/European Association of Cardiovascular Imaging 2016 recommendations update, irrespective of the experience level of the observer.

Published
2019

18. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American society of echocardiography and the European association of cardiovascular imaging

Author

Elyse Foster, Kirk T. Spencer, Denisa Muraru, Jonathan Afilalo, Roberto M. Lang, Tatiana Kuznetsova, Luigi P. Badano, Michael H. Picard, Steven A. Goldstein, Jens-Uwe Voigt, Laura Ernande, Anderson C. Armstrong, Wendy Tsang, Frank A. Flachskampf, Lawrence G. Rudski, Victor Mor-Avi, Patrizio Lancellotti, Ernst Rietzschel, Lang Roberto, M, Badano, L, Mor-Avi, V, Afilalo, J, Armstrong, A, Ernande, L, Flachskampf Frank, A, Foster, E, Goldstein Steven, A, Kuznetsova, T, Lancellotti, P, Muraru, D, Picard Michael, H, Rietzschel Ernst, R, Rudski, L, Spencer Kirk, T, Tsang, W, Voigt, J, Victor, M, and Retzschel Ernst, R

Subjects
Male, Transthoracic echocardiography, Ventricular Dysfunction, Right, Left, Echocardiography, Three-Dimensional, Speckle tracking echocardiography, PATIENTS GREATER-THAN-OR-EQUAL-TO-65 YEARS, Doppler echocardiography, Heart Ventricle, Ventricular Dysfunction, Left, Normal values, Nuclear Medicine and Imaging, Medicine and Health Sciences, Ventricular Dysfunction, LEFT ATRIAL VOLUME, Myocardial infarction, Societies, Medical, Ejection fraction, AORTIC-VALVE IMPLANTATION, medicine.diagnostic_test, Medicine (all), Doppler, General Medicine, Adult echocardiography, Echocardiography, Doppler, Europe, Right, medicine.vein, Ventricular function, Adult, Female, Forecasting, Humans, Sensitivity and Specificity, United States, Practice Guidelines as Topic, Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Echocardiography, Cardiology, End-diastolic volume, MULTIDETECTOR COMPUTED-TOMOGRAPHY, Radiology, Human, TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY, United State, SPECKLE-TRACKING ECHOCARDIOGRAPHY, ACUTE MYOCARDIAL-INFARCTION, medicine.medical_specialty, Heart Ventricles, Inferior vena cava, GLOBAL LONGITUDINAL STRAIN, Normal value, LEFT-VENTRICULAR MASS, Internal medicine, Medical, medicine, Radiology, Nuclear Medicine and imaging, Medical physics, Societie, End-systolic volume, business.industry, INFERIOR VENA-CAVA, Stroke Volume, medicine.disease, Cardiac chamber, Three-Dimensional, business, Societies
Abstract

The rapid technological developments of the past decade and the changes in echocardiographic practice brought about by these developments have resulted in the need for updated recommendations to the previously published guidelines for cardiac chamber quantification, which was the goal of the joint writing group assembled by the American Society of Echocardiography and the European Association of Cardiovascular Imaging. This document provides updated normal values for all four cardiac chambers, including three-dimensional echocardiography and myocardial deformation, when possible, on the basis of considerably larger numbers of normal subjects, compiled from multiple databases. In addition, this document attempts to eliminate several minor discrepancies that existed between previously published guidelines. ispartof: Journal of the American Society of Echocardiography vol:28 issue:1 pages:1-39 ispartof: location:United States status: published

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results